KRAS and non-small cell lung carcinoma: Further, it has been shown that PI3K inhibition stimulates MEK/Erk-dependent reactivation of Akt, thus targeting PI3K alone most likely will not be sufficient to sensitize KRAS-mutant NSCLC cells to irradiation.